Literature DB >> 6089653

Comparative activities of aztreonam and cefotaxime against Escherichia coli and Bacteroides spp. in pure and mixed cultures.

F Soriano, M C Ponte.   

Abstract

The activities of aztreonam and cefotaxime against one Escherichia coli strain and three Bacteroides strains have been studied by using pure and mixed cultures of aerobic and anaerobic bacteria. A fixed concentration (8 micrograms/ml) of cefotaxime or aztreonam killed E. coli that was exposed in pure culture, but the pressure of Bacteroides spp. in the same system deteriorated cefotaxime, allowing the full growth of E. coli after 24 h. On the other hand, the presence of Bacteroides spp. produced less deterioration of aztreonam, which reduced the initial E. coli inoculum. This observation could be useful in clinical practice when treating mixed aerobic and anaerobic infections.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6089653      PMCID: PMC179913          DOI: 10.1128/AAC.26.1.39

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  8 in total

1.  Activity of HR 756 against Haemophilus influenzae, Bacteroides fragilis and Gram-negative rods.

Authors:  F A Drasar; W Farrell; A J Howard; C Hince; T Leung; J D Williams
Journal:  J Antimicrob Chemother       Date:  1978-09       Impact factor: 5.790

2.  SQ 26,776: in-vitro antibacterial activity and susceptibility to beta-lactamases.

Authors:  I Phillips; A King; K Shannon; C Warren
Journal:  J Antimicrob Chemother       Date:  1981-12       Impact factor: 5.790

3.  Monobactams--monocyclic beta-lactam antibiotics produced by bacteria.

Authors:  R B Sykes; D P Bonner; K Bush; N H Georgopapadakou; J S Wells
Journal:  J Antimicrob Chemother       Date:  1981-12       Impact factor: 5.790

4.  In-vitro activity of the monobactam, SQ 26,776, against Gram-negative bacteria and its stability to their beta-lactamases.

Authors:  D M Livermore; J D Williams
Journal:  J Antimicrob Chemother       Date:  1981-12       Impact factor: 5.790

5.  Reciprocal antimicrobial synergism between Escherichia coli and Bacteroides fragilis in the presence of metronidazole.

Authors:  F Soriano; M C Ponte; M C Gaspar
Journal:  J Clin Pathol       Date:  1982-10       Impact factor: 3.411

6.  Microbial synergy in experimental intra-abdominal abscess.

Authors:  A B Onderdonk; J G Bartlett; T Louie; N Sullivan-Seigler; S L Gorbach
Journal:  Infect Immun       Date:  1976-01       Impact factor: 3.441

7.  Activity of cefotaxime and metronidazole against bacteroides and Escherichia coli alone and in mixed culture.

Authors:  F Soriano; C Ponte; M Santamaría
Journal:  J Antimicrob Chemother       Date:  1983-07       Impact factor: 5.790

8.  In vitro activity of azthreonam, a monobactam antibiotic.

Authors:  N V Jacobus; M C Ferreira; M Barza
Journal:  Antimicrob Agents Chemother       Date:  1982-11       Impact factor: 5.191

  8 in total
  3 in total

1.  In vitro activity of daptomycin-metronidazole combinations against mixed bacterial cultures: reduced activity of metronidazole against Bacteroides species in the presence of Enterococcus faecalis.

Authors:  E Nagy; H Werner; W Heizmann
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-04       Impact factor: 3.267

2.  Aztreonam concentration in abdominal tissues and bile.

Authors:  R E Condon; L T Friedhoff; C E Edmiston; B Levinson
Journal:  Antimicrob Agents Chemother       Date:  1986-06       Impact factor: 5.191

3.  Comparative antimicrobial efficacy of Metapex, Metronidazole, BioPure MTAD, Aztreonam on Bacteroides fragilis and Propionibacterium acne.

Authors:  Rajkumar Balakrishnan; Sandeep Dubey; Tapan Kumar N Dhole; Lalit C Boruah; Sanjeev Srivastava
Journal:  J Conserv Dent       Date:  2013-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.